TORVANTA
Other · S&P 500 · data as of 2026-10-05

ANIP stock analysis: ANIP

ANIP (ANIP) is an S&P 500 company in Other. It grades strongest on growth and weakest on momentum.

The model's view of ANIP · subscribers

Where ANIP ranks among the 1,500 U.S. stocks the model scores each trading day, its expected return, the evidence for and against it, and whether the model portfolio holds it. The grades below describe the company's data; they are not the model's view.

See plans
What's happening with ANIP · updated 2026-10-05 · from prices and SEC filings

ANIP price performance

ANIP against the S&P 500, one year
-20%+0%+20%S&P 500 +18%ANIP -21%2025-09-292026-10-05
Year to date-8.1%S&P 500 +14.5% · behind by 22.6 pts
1 year-19.0%S&P 500 +17.0% · behind by 36.1 pts
3 years+23.8%S&P 500 +89.3% · behind by 65.5 pts
5 years+117.9%S&P 500 +91.3% · ahead by 26.6 pts

Total returns with dividends reinvested.

ANIP factor grades

Each grade compares ANIP with the rest of its sector (A+ best, F worst); the numbers behind it are shown with the typical figure for its peers.

B+ValueP/E 15.7x (industry 20.1x)FCF yield 10.9% (industry 6.0%)
A-GrowthRevenue growth +31% (industry +8%)
B+ProfitabilityOperating margin 15.4% (industry 9.6%)ROIC 21.2% (industry 10.1%)
D+Momentum12-month change -19%From 52-wk high -24%

ANIP in plain numbers

ANIP key statistics

SectorOther
Industryn/a
IndexS&P 500
Market value$1.6B
Revenue growth (y/y)+31%
Free-cash-flow yield10.9%
Dividend yield0.0%
Next earnings (expected)2026-10-09
Valuation measures
Market value$1.6B
Enterprise value$1.5B
P/E (trailing)15.7x
Forward P/E (Torvanta estimate)11.7x
PEG (Torvanta estimate)0.34
Price / sales1.6x
Price / book2.7x
EV / revenue1.6x
EV / EBITDA6.5x
Financial highlights
Revenue, last 12 months$1.0B
Net income, last 12 months$108.3M
EPS, last 12 months (GAAP)$4.63
Operating margin15.4%
Net margin11.1%
Return on equity21.0%
Return on invested capital21.2%
Cash$360.2M
Total debt$301.5M
Debt / equity0.50x
Free cash flow, last 12 months$173.0M
Interest cover4.8x
Current ratio2.91x

Company figures from its latest SEC filings; market value and returns from end-of-day prices.

ANIP earnings trends

Revenue vs earnings
-$24.2M$48.4M$120.9M$193.5M$266.0MSep 2024 Revenue: $148.3MDec 2024 Revenue: $190.6MMar 2025 Revenue: $197.1MJun 2025 Revenue: $211.4MSep 2025 Revenue: $227.8MDec 2025 Revenue: $247.1MMar 2026 Revenue: $237.5MJun 2026 Revenue: $266.0MSep 2024 Net income: -$24.2MDec 2024 Net income: -$10.3MMar 2025 Net income: $15.7MJun 2025 Net income: $8.5MSep 2025 Net income: $26.6MDec 2025 Net income: $27.5MMar 2026 Net income: $29.5MJun 2026 Net income: $24.7MSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Net margin: -16.3%Net margin: -5.4%Net margin: 8.0%Net margin: 4.0%Net margin: 11.7%Net margin: 11.1%Net margin: 12.4%Net margin: 9.3%-16%-2%12%■ Revenue ■ Net income ━ Net margin
Earnings per share$-1.3$-0.6$0.0$0.6$1.3Sep 2024 EPS (GAAP, diluted): $-1.3Dec 2024 EPS (GAAP, diluted): $-0.6Mar 2025 EPS (GAAP, diluted): $0.7Jun 2025 EPS (GAAP, diluted): $0.4Sep 2025 EPS (GAAP, diluted): $1.1Dec 2025 EPS (GAAP, diluted): $1.2Mar 2026 EPS (GAAP, diluted): $1.3Jun 2026 EPS (GAAP, diluted): $1.1Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026■ EPS (GAAP, diluted) Change from a year earlier: Mar 2026 +86% · Jun 2026 +192%

From the company's 10-Q and 10-K filings with the SEC.

ANIP financials (from SEC filings)

Fiscal yearFY2021FY2022FY2023FY2024FY2025
Revenue$216.1M$316.4M$486.8M$614.4M$883.4M
Net income-$42.6M-$47.9M$18.8M-$18.5M$78.3M
EPS (GAAP)$-3.40$-3.05$0.82$-1.14$3.35
Free cash flow$765K-$40.1M$110.1M$47.8M$171.4M

ANIP earnings history

ReportedEPS (GAAP)EPS y/yRevenue y/yStock vs S&P 500, 2 days
2026-08-07$1.05+192%+26%-8.9%
2026-05-08$1.28+86%+20%-7.3%
2026-02-27$1.17n/a+30%-2.1%
2026-01-12$1.17n/a+30%+7.9%
2025-11-10$1.13n/a+54%-3.9%
2025-11-07$1.13n/a+54%-3.1%

About ANIP

HeadquartersPrinceton, NJ
Industry (SEC code)Pharmaceutical Preparations
Fiscal year endsDecember 31
Incorporated inDE
Listed onNasdaq
FormerlyBIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC

From the company's SEC registration record.

Companies similar to ANIP

CompanyMarket valueP/ERevenue growthOperating margin12-month change
ANIP ANIP$1.6B15.7x+31%15.4%-19%
AESI AESI$1.6Bn/a-8%-8.3%+9%compare
OMCL OMCL$1.6B41.2x+8%4.6%+12%compare
CNXC CNXC$1.6Bn/a+4%-10.2%-44%compare
DEI DEI$1.6Bn/a+1%n/a-33%
PRKS PRKS$1.6B13.4x-4%19.2%-38%
WWW WWW$1.6B14.7x+7%8.7%-24%

All Other stock ratings

Frequently asked questions

Is ANIP stock a buy?

Torvanta does not tell individuals what to buy. Its grades for ANIP are shown above. Subscribers see the model's rank, expected return and whether the model portfolio holds it. This is research, not a recommendation.

What is ANIP's P/E ratio?

ANIP trades at about 15.7 times its last 12 months of GAAP earnings reported to the SEC, and about 11.7 times Torvanta's own estimate of the next 12 months.

When does ANIP report earnings next?

Based on its filing history, Torvanta expects ANIP to report around 2026-10-09.

Does ANIP pay a dividend?

Yes. Its dividend yield is about 0.0%.

How has ANIP performed against the S&P 500?

Over the past year ANIP returned -19.0%, against +17.0% for the S&P 500, dividends reinvested.

See the model's view

Subscribers get the model's rank and expected return for every covered company, the reasoning behind each, and the Torvanta model portfolio's trades each trading day, sized and explained, at three risk levels.

See plans Or get the free weekly newsletter

Torvanta is research only - not investment advice and not a recommendation to buy or sell any security. Grades describe a company's reported data against its sector; they are not the model's view, change as data changes and can be wrong. Financial figures come from the company's SEC filings; returns include reinvested dividends. Past performance does not predict future results.

All stock ratings · Stock lists · AI stock research · Model portfolio · Research · Disclaimer